• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似微生物性角膜炎治疗结果的危险因素。氧氟沙星研究组。

Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.

作者信息

Morlet N, Minassian D, Butcher J

出版信息

Br J Ophthalmol. 1999 Sep;83(9):1027-31. doi: 10.1136/bjo.83.9.1027.

DOI:10.1136/bjo.83.9.1027
PMID:10460769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1723169/
Abstract

BACKGROUND

Primary treatment for suspected microbial keratitis is generally successful. Although risks such as contact lens use are well recognised as causative factors for microbial keratitis, little is known about the risk factors that influence treatment outcome. The present study evaluates the risk factors assessed at diagnosis as prognostic indicators of primary treatment failure.

METHODS

Patients were prospectively enrolled in the ofloxacin treatment trial and data concerning symptoms, treatments, past and concurrent eye disease were collected along with the measurement of corneal ulcer size at the slit lamp. All patients were scraped for microbiological investigation, and treated with either ofloxacin (0. 3%) or standard therapy of fortified cefuroxime and gentamicin drops. Treatment success was complete healing of the ulcer with zero dimensions of the epithelial defect within 2 weeks of start of treatment. The important prognostic indicators were selected by comparison among those who failed treatment, had delayed healing, or were culture positive with other patients using univariate and stratified analysis. These were then used in a Poisson model for multiple regression analysis to estimate the relative risk of the main prognostic variables.

RESULTS

Of the 118 patients enrolled in the study, 14 were identified as primary treatment failures, 17 had slow healing, and 15 indolent ulcers. There were 49 culture positive patients. The multivariate analysis identified that large culture positive ulcers in patients 60 years or older had 5.5 times the risk of primary treatment failure (p<0.001). Significant predictors of slow healing were previous ocular disease and a positive culture; significant predictors of indolent ulceration were previous ocular disease and steroid use at diagnosis; the main predictor of a culture positive result was ulcer size.

CONCLUSIONS

Elderly patients with large ulcers were more likely to be culture positive, fail primary therapy, and require surgical intervention. A positive microbial culture provided prognostic information regardless of the organism isolated. However, this information was of less value for those with small ulcers and for younger patients.

摘要

背景

疑似微生物性角膜炎的初始治疗通常是成功的。尽管诸如佩戴隐形眼镜等风险已被公认为微生物性角膜炎的致病因素,但对于影响治疗结果的危险因素却知之甚少。本研究评估了在诊断时评估的危险因素作为初始治疗失败的预后指标。

方法

前瞻性纳入患者进行氧氟沙星治疗试验,收集有关症状、治疗、既往和并发眼病的数据,同时在裂隙灯下测量角膜溃疡大小。所有患者均进行刮片进行微生物学检查,并用氧氟沙星(0.3%)或强化头孢呋辛和庆大霉素滴眼液的标准疗法进行治疗。治疗成功定义为在开始治疗后2周内溃疡完全愈合且上皮缺损尺寸为零。通过对治疗失败、愈合延迟或培养阳性的患者与其他患者进行单因素和分层分析比较,选择重要的预后指标。然后将这些指标用于泊松模型进行多元回归分析,以估计主要预后变量的相对风险。

结果

在纳入研究的118例患者中,14例被确定为初始治疗失败,17例愈合缓慢,15例为顽固性溃疡。有49例培养阳性患者。多因素分析确定,60岁及以上患者中培养阳性的大溃疡初始治疗失败风险是其5.5倍(p<0.001)。愈合缓慢的显著预测因素是既往眼部疾病和培养阳性;顽固性溃疡的显著预测因素是既往眼部疾病和诊断时使用类固醇;培养阳性结果的主要预测因素是溃疡大小。

结论

患有大溃疡的老年患者更可能培养阳性、初始治疗失败并需要手术干预。微生物培养阳性提供了预后信息,无论分离出何种微生物。然而,对于小溃疡患者和年轻患者,此信息的价值较小。

相似文献

1
Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.疑似微生物性角膜炎治疗结果的危险因素。氧氟沙星研究组。
Br J Ophthalmol. 1999 Sep;83(9):1027-31. doi: 10.1136/bjo.83.9.1027.
2
Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.氧氟沙星单药疗法用于微生物性角膜炎的初始治疗:一项与传统双联疗法对比的双盲、随机、对照试验。氧氟沙星研究组
Ophthalmology. 1997 Nov;104(11):1902-9.
3
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.氧氟沙星与头孢唑林和妥布霉素治疗细菌性角膜炎的疗效比较。细菌性角膜炎研究小组报告。 (注:原文中“of ofloxacin”多了一个of)
Arch Ophthalmol. 1995 Oct;113(10):1257-65. doi: 10.1001/archopht.1995.01100100045026.
4
Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.0.3%氧氟沙星局部用药与强化妥布霉素加头孢唑林治疗细菌性角膜炎的比较。
Eye (Lond). 1999 Dec;13 ( Pt 6):744-7. doi: 10.1038/eye.1999.220.
5
Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.0.3%氧氟沙星与0.3%环丙沙星滴眼液治疗培养阳性细菌性角膜炎患者的细菌学及临床疗效
Cornea. 2001 Mar;20(2):175-8. doi: 10.1097/00003226-200103000-00013.
6
Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.局部应用0.3%氧氟沙星与强化妥布霉素-头孢唑林治疗细菌性角膜炎的比较。
Infection. 2000 May-Jun;28(3):149-52. doi: 10.1007/s150100050068.
7
[Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis].0.3%左氧氟沙星滴眼液治疗急性细菌性结膜炎和细菌性角膜炎的临床研究
Yan Ke Xue Bao. 2000 Jun;16(2):146-8.
8
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.莫西沙星治疗细菌性角膜炎的临床疗效:一项随机临床试验。
Ophthalmology. 2007 Sep;114(9):1622-9. doi: 10.1016/j.ophtha.2006.12.011.
9
Cytotoxic effects of the fluoroquinolone ofloxacin on stromal keratocytes.氟喹诺酮类药物氧氟沙星对角膜基质细胞的细胞毒性作用。
Cornea. 2007 Feb;26(2):241; author reply 241. doi: 10.1097/01.ico.0000244872.00503.4a.
10
Treatment of experimental bacterial keratitis with topical trovafloxacin.局部用曲伐沙星治疗实验性细菌性角膜炎。
Arch Ophthalmol. 2004 Jan;122(1):65-9. doi: 10.1001/archopht.122.1.65.

引用本文的文献

1
Factors Associated with Vision Outcomes in Microbial Keratitis: A Multisite Prospective Cohort Study.微生物性角膜炎视力预后的相关因素:一项多中心前瞻性队列研究。
Ophthalmology. 2025 Jul;132(7):830-841. doi: 10.1016/j.ophtha.2025.02.004. Epub 2025 Feb 8.
2
Infectious keratitis in Western New York: a 10-year review of patient demographics, clinical management, and treatment failure.纽约西部的感染性角膜炎:对患者人口统计学、临床管理及治疗失败情况的10年回顾
Front Ophthalmol (Lausanne). 2024 Dec 11;4:1469966. doi: 10.3389/fopht.2024.1469966. eCollection 2024.
3
Clinical perspective and outcome of culture-negative microbial keratitis: A retrospective study.培养阴性微生物角膜炎的临床观察及结果:一项回顾性研究。
Indian J Ophthalmol. 2024 Aug 1;72(8):1130-1135. doi: 10.4103/IJO.IJO_2794_23. Epub 2024 Jul 29.
4
Evaluation of photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) in feline infectious keratitis-patient demographics, treatment protocols, risk factors, and treatment outcome: a retrospective study.猫传染性角膜炎患者人口统计学、治疗方案、危险因素及治疗结果中用于角膜炎-角膜交联(PACK-CXL)的光活化发色团评估:一项回顾性研究
Vet Ophthalmol. 2025 Mar;28(2):330-340. doi: 10.1111/vop.13228. Epub 2024 May 5.
5
Evaluation of risk factors for treatment failure in canine patients undergoing photoactivated chromophore for keratitis - corneal cross-linking (PACK-CXL): a retrospective study using additive bayesian network analysis.犬用光激活染色剂治疗角膜炎-角膜交联术(PACK-CXL)失败风险因素的评估:使用加性贝叶斯网络分析的回顾性研究。
BMC Vet Res. 2023 Nov 2;19(1):227. doi: 10.1186/s12917-023-03779-x.
6
Clinical comparative analysis of culture-proven bacterial keratitis according to prior topical steroid use: a retrospective study in a tertiary referral center of South Korea.根据既往局部使用皮质类固醇情况对培养阳性细菌性角膜炎的临床对比分析:韩国一家三级转诊中心的回顾性研究。
Sci Rep. 2023 Sep 2;13(1):14477. doi: 10.1038/s41598-023-41588-2.
7
Comparison of culture, confocal microscopy and PCR in routine hospital use for microbial keratitis diagnosis.在微生物角膜炎的常规临床诊断中,比较培养法、共聚焦显微镜检查法和 PCR 法。
Eye (Lond). 2022 Nov;36(11):2172-2178. doi: 10.1038/s41433-021-01812-7. Epub 2021 Nov 5.
8
Medical History, Clinical Features, Treatment Outcome and Its Predictors Among Infectious Keratitis Patients in Jimma University Medical Center, Southwest Ethiopia: Prospective Observational Study.埃塞俄比亚西南部吉马大学医学中心感染性角膜炎患者的病史、临床特征、治疗结果及其预测因素:前瞻性观察研究
Clin Ophthalmol. 2021 Mar 22;15:1223-1237. doi: 10.2147/OPTH.S291880. eCollection 2021.
9
Laboratory Results, Epidemiologic Features, and Outcome Analyses of Microbial Keratitis: A 15-Year Review From St. Louis.实验室结果、流行病学特征和微生物性角膜炎的结局分析:来自圣路易斯的 15 年回顾。
Am J Ophthalmol. 2019 Feb;198:54-62. doi: 10.1016/j.ajo.2018.09.032. Epub 2018 Oct 9.
10
Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.三级转诊中心铜绿假单胞菌与恶臭假单胞菌角膜炎的临床特征及抗生素敏感性比较:一项回顾性研究
BMC Ophthalmol. 2018 Aug 20;18(1):204. doi: 10.1186/s12886-018-0882-3.

本文引用的文献

1
The importance of initial management in the treatment of severe infectious corneal ulcers.初始管理在严重感染性角膜溃疡治疗中的重要性。
Ophthalmology. 1995 Dec;102(12):1943-8. doi: 10.1016/s0161-6420(95)30771-3.
2
Initial treatment of microbial keratitis.微生物性角膜炎的初始治疗
CLAO J. 1996 Apr;22(2):136-40.
3
The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis.涂片、培养及抗生素敏感性试验在疑似感染性角膜炎治疗中的作用。
Ophthalmology. 1996 Jan;103(1):23-8. doi: 10.1016/s0161-6420(96)30738-0.
4
Empirical or culture-guided therapy for microbial keratitis? A plea for data.微生物性角膜炎的经验性治疗还是基于培养结果的治疗?呼吁提供数据。
Arch Ophthalmol. 1996 Jan;114(1):84-7. doi: 10.1001/archopht.1996.01100130080013.
5
Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis.局部应用环丙沙星与传统抗生素疗法治疗溃疡性角膜炎的比较。
Am J Ophthalmol. 1993 Apr 15;115(4):471-7. doi: 10.1016/s0002-9394(14)74449-6.
6
0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group.0.3%环丙沙星眼膏治疗细菌性角膜炎。环丙沙星眼膏/细菌性角膜炎研究组。
Arch Ophthalmol. 1993 Sep;111(9):1210-8. doi: 10.1001/archopht.1993.01090090062020.
7
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.氧氟沙星与头孢唑林和妥布霉素治疗细菌性角膜炎的疗效比较。细菌性角膜炎研究小组报告。 (注:原文中“of ofloxacin”多了一个of)
Arch Ophthalmol. 1995 Oct;113(10):1257-65. doi: 10.1001/archopht.1995.01100100045026.
8
Demographic and predisposing factors in corneal ulceration.角膜溃疡的人口统计学及诱发因素。
Arch Ophthalmol. 1983 Oct;101(10):1545-8. doi: 10.1001/archopht.1983.01040020547007.
9
Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis.影响化脓性角膜炎预后的宿主、微生物和药理学因素。
Br J Ophthalmol. 1987 Feb;71(2):96-101. doi: 10.1136/bjo.71.2.96.
10
Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.局部应用诺氟沙星与妥布霉素治疗眼部外感染的安全性和有效性。
Antimicrob Agents Chemother. 1988 Dec;32(12):1820-4. doi: 10.1128/AAC.32.12.1820.